Hosted on MSN9m
Organon (NYSE:OGN) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations SignificantlyPharmaceutical company Organon (NYSE:OGN) reported Q4 CY2024 results , but sales were flat year on year at $1.59 billion. On ...
GE HealthCare Technologies delivered solid fourth-quarter earnings, but domestic and international revenue growth remained ...
Nutriband Inc. (NASDAQ:NTRB), a developer of transdermal pharmaceutical products, has announced an exclusive partnership with Kindeva Drug Delivery to develop Aversaâ„¢ Fentanyl, a potential ...
When done safely and securely, automated inbound engagement can provide significant benefits for pharmaceutical companies.
As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong dollar and as the medical equipment maker's clients reduce inventory levels, ...
(WST) on Thursday reported fourth-quarter profit of $130.1 million. The Exton, Pennsylvania-based company said it had net ...
Tarsus Pharmaceuticals is making a splash with Xdemvy, an eye drop that kills the demodex mites that cause inflammation and ...
Northern Kentucky lawmaker wants overhaul of bill meant to protect income that some Kentucky hospitals say is essential for ...
CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...
CVS appears uniquely positioned to improve health outcomes, and we appreciate management's focus on better leveraging its assets through digital and other means to bring a more consumer-centric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results